Neurocarrus
Latest round
- Seed
Last raised
- Oct 2017
Total raised
- Undisclosed
Investors
- 2
About Neurocarrus
Founded in 2015 and based in California, US, Neurocarrus Inc. is a biotechnology company that develops novel therapy to treat pain without addiction-forming medications or disruption of muscular control. It uses protein engineering to develop a novel, non-opioid remedial that targets sensory neurons to stop pain wave before it gets to the brain. The company's N-001 therapeutic is designed to treat the physiological symptoms of pain without invasive surgical procedures or systemically absorbed drugs.
Who invested in Neurocarrus
2 investors across 1 round
See all investors in Neurocarrus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 27, 2017
Amount
Undisclosed
Investors
Questions about Neurocarrus
Who invested in Neurocarrus?
Neurocarrus has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neurocarrus raised?
Neurocarrus has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Neurocarrus last raise money?
Neurocarrus's most recent round on record is a Seed, in Oct 2017.
What does Neurocarrus do?
Founded in 2015 and based in California, US, Neurocarrus Inc.
Where is Neurocarrus headquartered?
Neurocarrus is headquartered in San Francisco, US.
Which VCs invest in companies like Neurocarrus?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Neurocarrus's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Neurocarrus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.